Oncolytics Biotech (TSE:ONC) has released an update.
Oncolytics Biotech Inc., a leader in cancer immunotherapy, announces participation in the upcoming RBC Capital Markets Global Healthcare Conference with a fireside chat featuring CEO Dr. Matt Coffey. The event is scheduled for May 15, 2024, and will include one-on-one investor meetings; a live webcast will be available on the company’s Investor Relations page. Oncolytics is advancing its immunotherapeutic agent pelareorep in clinical trials, targeting metastatic breast and pancreatic cancers with FDA Fast Track designations.
For further insights into TSE:ONC stock, check out TipRanks’ Stock Analysis page.
